Biological E Has Received the Drugs Controller General of India's Approval for ... - Latest Tweet by IANS Tweets

Biological E has received the Drugs Controller General of India's (DCGI) approval for conducting Phase 3 comparator safety and immunogenicity trial of its Corbevax vaccine in adults after the subject expert committee's (SEC) review of Phase 1 and 2 clinical trials data. pic.twitter.com/Xpbpu4pKWy— IANS Tweets (@ians_india) September 3, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)